The delivery of small molecules, proteins and biologic drugs, nucleic acids and other molecular therapies relies on the accessibility of the drug, which is highly dependent on the ability to manage solubility, stability, biodistribution and pharmacokinetics of the drug. The Drug Carriers for Medicine and Biology Gordon Research Conference (GRC), and its accompanying Gordon Research Seminar (GRS) provide a key platform for discussion and dissemination of critical developments in the design of drug delivery systems to meet the many unique challenges of this field. Addressing these issues requires an interdisciplinary approach that engages basic biology and physiology, chemistry and physics that inform design, as well as engineering and clinical perspectives. The GRC provides a unique environment that successfully brings these groups together to discuss and debate fundamental questions about delivery, and to share new innovations in the field.
The specific aims of this GRC/GRS are to 1) To provide a forum for discussion of the key barriers to delivery and physiological understanding to inform carrier design. 2) Facilitate discussion of delivery systems in an intellectually and culturally diverse, multidisciplinary environment, with input from engineering, physiological, regulatory and translational perspectives. 3) To enable presentation and discussion of new innovations and cutting edge research in the drug delivery field and 4) Create opportunities for young faculty and other early investigators in the field to present their work and to build critical relationships and partnerships for professional advancement. The theme and subtitle for the 2016 GRC is Understanding physiological barriers to inform design. The key barriers to delivery are the focus of sessions, ranging from endothelial and epithelial barriers to extracellular matrix and intracellular trafficking. Areas of focus in the seminar inclue cancer, vaccines, infectious disease, nanomedicine approaches, and delivery of drugs to the brain, lung, gut and other organs. The GRS that takes place prior to the GRC enables graduate students and postdoctoral associates to examine the field and address important questions from their own perspectives as early investigators who are thinking toward the future of the field. Speakers will be selected from among research trainees across a broad range of institutions and disciplines. The 2016 GRS theme, which is Translating Basic Science to Clinical Success: Bridging the Gap Between Successful Drug Carriers in vitro and in vivo, will provide a forum for discussion that connects ongoing laboratory research and the kinds of issues that might ultimately determine translational success. The GRS will also feature a plenary speaker that can provide deep perspective on this question, and discussion leaders chosen from among leaders in the field who can provide background and perspective during the discussions. Funding is requested to enable attendance of students, postdoctoral investigators, and early career faculty, as well as a diverse group of speakers and discussion leaders, including underrepresented minorities and women.
One of the most critical challenges of modern medicine is the ability to get drugs to the appropriate point of treatment within the body. The delivery of small molecules, proteins and biologic drugs, nucleic acids and other molecular therapies relies on the engineering of materials or systems based on scientific and medical knowledge. The Drug Carriers for Medicine and Biology Gordon Research Conference (GRC), and its accompanying Gordon Research Symposium (GRS) provide a key platform for discussion and dissemination of critical developments in the design of drug delivery systems to meet the many unique challenges of this field.
